Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 7 min ago
Peer-reviewedCC BYCureus

Apparent Histologic Discordance in Recurrent Testicular Germ Cell Tumor With Bulky Retroperitoneal Disease and Inferior Vena Cava Compression: A Case Report and Brief Review of the Literature.

4 affiliations
  1. 1General Surgery, American University of the Caribbean School of Medicine, Cupecoy, SXM.
  2. 2Internal Medicine, Jackson Memorial Hospital, Miami, USA.
  3. 3Pathology, University of Miami/Jackson Health System, Miami, USA.
  4. 4Internal Medicine, Universidad Hispanoamericana, San José, CRI.

Abstract

Testicular germ cell tumors are highly curable, but bulky retroperitoneal recurrence creates diagnostic uncertainty when a limited biopsy does not capture all components of the primary tumor. A 35-year-old man presented with abdominal pain radiating to the back and intermittent constipation nearly five years after an orchiectomy for a 6.5-cm mixed germ cell tumor consisting of seminoma (80%) and embryonal carcinoma (20%) with lymphovascular invasion. CT showed a heterogeneous 14.1-cm retroperitoneal nodal mass with near-complete inferior vena cava effacement. Retrospective comparison with prior imaging identified a 2.1-cm focus at the same site on a June 2022 study; no intervening imaging was available. Lactate dehydrogenase (LDH) was 630 U/L (2.25 times the upper limit of normal), beta-human chorionic gonadotropin (β-hCG) was minimally elevated, and alpha-fetoprotein (AFP) was normal. A core biopsy showed seminoma with focal necrosis; no nonseminomatous component was identified in the sampled tissue. With the pulmonary micronodules regarded as indeterminate rather than metastatic, the available data were consistent with cN3 cM0 S2, stage IIIB. Because the primary tumor contained embryonal carcinoma and because core sampling could not exclude unsampled nonseminoma, the oncology team applied an intermediate-risk nonseminomatous germ cell tumor framework and initiated curative-intent bleomycin, etoposide, and cisplatin, with four cycles planned. At the last available follow-up, the patient had completed the inpatient portion of cycle 1 without major acute toxicity and reported improved pain; neither treatment completion nor radiographic response was available. Apparent histologic discordance on core biopsy should be interpreted in light of the original pathology, serum markers, imaging, and multidisciplinary assessment.

Related

  1. Case Report: Giant congenital hydronephrosis presenting as massive retroperitoneal cystic lesion with literature review
    Wen Yan, Mengmeng Xiao, Ming yi Li +2
    Frontiers in surgeryPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  2. Computed tomography findings of a retroperitoneal chronic expanding hematoma with multiple hemangiomas: A case report and literature review
    Takayoshi Shinya, Kanako Yoshida, Takeshi Iwasa +6
    Radiology case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Histologic heterogeneity in synchronous bilateral breast cancer: a case report and literature review
    Xuedi Yuan, Wen Liu, Xiuxia Liu +2
    Frontiers in oncologyPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCCrossref
  4. Anaesthesia management of a giant retroperitoneal liposarcoma: a case report and literature review.
    Fei Huo, Bin An, Hansheng Liang +4
    Frontiers in surgeryPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  5. Case report and literature review: histologic transformation from EGFR-mutant lung adenocarcinoma to squamous cell carcinoma with newly detected SMAD4 and ATM variants
    Chao Wang, Shuo Wang, Daixi Wu +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
BibTeX
@article{bidgoli2026apparent,
  title = {{Apparent Histologic Discordance in Recurrent Testicular Germ Cell Tumor With Bulky Retroperitoneal Disease and Inferior Vena Cava Compression: A Case Report and Brief Review of the Literature.}},
  author = {Alireza Izadian Bidgoli and Alberto Gomez Veliz and Nikunj Shah and Hellen Ailette Gomez Usatorres and Alberto Gomez Usatorres},
  journal = {Cureus},
  year = {2026},
  month = sep,
  doi = {10.7759/cureus.116587},
  url = {https://europepmc.org/article/MED/42904127},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Apparent Histologic Discordance in Recurrent Testicular Germ Cell Tumor With Bulky Retroperitoneal Disease and Inferior Vena Cava Compression: A Case Report and Brief Review of the Literature.
AU  - Alireza Izadian Bidgoli
AU  - Alberto Gomez Veliz
AU  - Nikunj Shah
AU  - Hellen Ailette Gomez Usatorres
AU  - Alberto Gomez Usatorres
PY  - 2026
DA  - 2026/09/20
JO  - Cureus
DO  - 10.7759/cureus.116587
UR  - https://europepmc.org/article/MED/42904127
AB  - Testicular germ cell tumors are highly curable, but bulky retroperitoneal recurrence creates diagnostic uncertainty when a limited biopsy does not capture all components of the primary tumor. A 35-year-old man presented with abdominal pain radiating to the back and intermittent constipation nearly five years after an orchiectomy for a 6.5-cm mixed germ cell tumor consisting of seminoma (80%) and embryonal carcinoma (20%) with lymphovascular invasion. CT showed a heterogeneous 14.1-cm retroperitoneal nodal mass with near-complete inferior vena cava effacement. Retrospective comparison with prior imaging identified a 2.1-cm focus at the same site on a June 2022 study; no intervening imaging was available. Lactate dehydrogenase (LDH) was 630 U/L (2.25 times the upper limit of normal), beta-human chorionic gonadotropin (β-hCG) was minimally elevated, and alpha-fetoprotein (AFP) was normal. A core biopsy showed seminoma with focal necrosis; no nonseminomatous component was identified in the sampled tissue. With the pulmonary micronodules regarded as indeterminate rather than metastatic, the available data were consistent with cN3 cM0 S2, stage IIIB. Because the primary tumor contained embryonal carcinoma and because core sampling could not exclude unsampled nonseminoma, the oncology team applied an intermediate-risk nonseminomatous germ cell tumor framework and initiated curative-intent bleomycin, etoposide, and cisplatin, with four cycles planned. At the last available follow-up, the patient had completed the inpatient portion of cycle 1 without major acute toxicity and reported improved pain; neither treatment completion nor radiographic response was available. Apparent histologic discordance on core biopsy should be interpreted in light of the original pathology, serum markers, imaging, and multidisciplinary assessment.
SN  - 2168-8184
ER  -